Structural comparison of four different antibodies interacting with human papillomavirus 16 and mechanisms of neutralization

Virology

Volumn 483, Issue , 2015, Pages 253-263

  Guan, Jian ^a   Bywaters, Stephanie M ^a   Brendle, Sarah A ^a   Lee, Hyunwook ^a   Ashley, Robert E ^a   Makhov, Alexander M ^b   Conway, James F ^b   Christensen, Neil D ^a   Hafenstein, Susan ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Conformation; Crosslinking; Cryo EM; Epitope; HPV16; Human papillomavirus; MAb; Neutralization; Stabilization; Virus fab complex

Indexed keywords

CAPSID PROTEIN; EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY H16.14J; MONOCLONAL ANTIBODY H16.1A; MONOCLONAL ANTIBODY H16.V5; MONOCLONAL ANTIBODY H263.A2; UNCLASSIFIED DRUG; NEUTRALIZING ANTIBODY; PROTEIN BINDING; VIRUS ANTIBODY;

ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; HUMAN PAPILLOMAVIRUS TYPE 16; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; VIRUS CAPSID; VIRUS MORPHOLOGY; VIRUS NEUTRALIZATION; CHEMISTRY; CRYOELECTRON MICROSCOPY; IMMUNOLOGY; SERODIAGNOSIS; ULTRASTRUCTURE;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16; MIRIDAE;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CRYOELECTRON MICROSCOPY; EPITOPE MAPPING; HUMAN PAPILLOMAVIRUS 16; NEUTRALIZATION TESTS; PROTEIN BINDING;

EID: 84929438770     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2015.04.016     Document Type: Article

References (56)

1. Baker T.S., Newcomb W.W., Olson N.H., Cowsert L.M., Olson C., Brown J.C. Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys. J. 1991, 60:1445-1456.
2. Bishop B., Dasgupta J., Klein M., Garcea R.L., Christensen N.D., Zhao R., Chen X.S. Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies. J. Biol. Chem. 2007, 282:31803-31811.
3. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J., Schiffman M.H., Moreno V., Kurman R., Shan K.V., International Biological Study on Cervical Cancer (IBSCC) Study Group Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 1995, 87:796-802.
4. Brendle S.A., Culp T.D., Broutian T.R., Christensen N.D. Binding and neutralization characteristics of a panel of monoclonal antibodies to human papillomavirus 58. J. Gen. Virol. 2010, 91:1834-1839.
5. Buck C.B., Pastrana D.V., Lowy D.R., Schiller J.T. Efficient intracellular assembly of papillomaviral vectors. J. Virol. 2004, 78:751-757.
6. Buck C.B., Thompson C.D., Pang Y.-Y.S., Lowy D.R., Schiller J.T. Maturation of papillomavirus capsids. J. Virol. 2005, 79:2839-2846.
7. Buck C.B., Pastrana D.V., Lowy D.R., Schiller J.T. Generation of HPV pseudovirions using transfection and their use in neutralization assays. Methods Mol. Med. 2005, 119:445-462.
8. Burk R.D., Chen Z., Van Doorslaer K. Human papillomaviruses: genetic basis of carcinogenicity. Public Health Genomics 2009, 12:281-290.
9. Cardone G., Moyer A.L., Cheng N., Thompson C.D., Dvoretzky I., Lowy D.R., Schiller J.T., Steven A.C., Buck C.B., Trus B.L. Maturation of the human papillomavirus 16 capsid. mBio 2014, 5. (e01104-e01104-14).
10. Carter J.J., Wipf G.C., Benki S.F., Christensen N.D., Galloway D.A. Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1. J. Virol. 2003, 77:11625-11632.
11. Castillo A. Human papillomavirus and carcinogenesis in the upper aero-digestive tract. Carcinogenesis 2013, online, InTech, (accessed 23.0414.). K. Tonissen (Ed.).
12. Chen H.-S., Conway M.J., Christensen N.D., Alam S., Meyers C. Papillomavirus capsid proteins mutually impact structure. Virology 2011, 412:378-383.
13. Christensen N.D. Cottontail rabbit papillomavirus (CRPV) model system to test antiviral and immunotherapeutic strategies. Antivir. Chem. Chemother. 2005, 16:355-362.
14. Christensen N.D., Kreider J.W., Kan N.C., DiAngelo S.L. The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes. Virology 1991, 181:572-579.
15. Christensen N.D., Dillner J., Eklund C., Carter J.J., Wipf G.C., Reed C.A., Cladel N.M., Galloway D.A. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology 1996, 223:174-184.
16. Christensen N.D., Cladel N.M., Reed C.A., Budgeon L.R., Embers M.E., Skulsky D.M., McClements W.L., Ludmerer S.W., Jansen K.U. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types. Virology 2001, 291:324-334.
17. Collaborative Computational Project, Number 4 1994 The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D: Biol. Crystallogr.. 50, 760-763.
18. Crow J.M. HPV: the global burden. Nature 2012, 488:S2-S3.
19. Culp T.D., Spatz C.M., Reed C.A., Christensen N.D. Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particles. Virology 2007, 361:435-446.
20. Dasgupta J., Bienkowska-Haba M., Ortega M.E., Patel H.D., Bodevin S., Spillmann D., Bishop B., Sapp M., Chen X.S. Structural basis of oligosaccharide receptor recognition by human papillomavirus. J. Biol. Chem. 2011, 286:2617-2624.
21. Day P.M., Schelhaas M. Concepts of papillomavirus entry into host cells. Curr. Opin. Virol. 2014, 4:24-31.
22. Day P.M., Thompson C.D., Buck C.B., Pang Y.-Y.S., Lowy D.R., Schiller J.T. Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J. Virol. 2007, 81:8784-8792.
23. Day P.M., Gambhira R., Roden R.B.S., Lowy D.R., Schiller J.T. Mechanisms of human papillomavirus type 16 neutralization by L2 cross-neutralizing and L1 type-specific antibodies. J. Virol. 2008, 82:4638-4646.
24. Deschuyteneer M., Elouahabi A., Plainchamp D., Plisnier M., Soete D., Corazza Y., Lockman L., Giannini S., Deschamps M. Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in CervarixTM, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine. Hum. Vaccin. 2010, 6:407-419.
25. Fabiola F., Chapman M.S. Fitting of high-resolution structures into electron microscopy reconstruction images. Structure 2005, 13:389-400.
26. Hafenstein S., Bowman V.D., Sun T., Nelson C.D.S., Palermo L.M., Chipman P.R., Battisti A.J., Parrish C.R., Rossmann M.G. Structural comparison of different antibodies interacting with parvovirus capsids. J. Virol. 2009, 83:5556-5566.
27. Hewat E.A., Blaas D. Structure of a neutralizing antibody bound bivalently to human rhinovirus 2. EMBO J. 1996, 15:1515-1523.
28. Kirnbauer R., Booy F., Cheng N., Lowy D.R., Schiller J.T. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 1992, 89:12180-12184.
29. Lee H., Brendle S.A., Bywaters S.M., Guan J., Ashley R.E., Yoder J.D., Makhov A.M., Conway J.F., Christensen N.D., Hafenstein S. A CryoEM study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment. J. Virol. 2014, (10.1128/JVI.02898-14).
30. Lyskov S., Chou F.-C., Conchúir S.Ó., Der B.S., Drew K., Kuroda D., Xu J., Weitzner B.D., Renfrew P.D., Sripakdeevong P., Borgo B., Havranek J.J., Kuhlman B., Kortemme T., Bonneau R., Gray J.J., Das R. Serverification of molecular modeling applications: the Rosetta Online Server that Includes Everyone (ROSIE). PLoS One 2013, 8:e63906.
31. Marur S., D'Souza G., Westra W.H., Forastiere A.A. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010, 11:781-789.
32. Mejia A.F., Culp T.D., Cladel N.M., Balogh K.K., Budgeon L.R., Buck C.B., Christensen N.D. Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV/Cottontail Rabbit Papillomavirus Chimeric Papillomavirus Particles. J. Virol. 2006, 80:12393-12397.
33. Monie A., Tsen S.-W.D., Hung C.-F., Wu T.-C. Therapeutic HPV DNA vaccines. Exp. Rev. Vaccines 2009, 8:1221-1235.
34. Pastrana D.V., Buck C.B., Pang Y.-Y.S., Thompson C.D., Castle P.E., FitzGerald P.C., Krüger Kjaer S., Lowy D.R., Schiller J.T. Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology 2004, 321:205-216.
35. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF chimera: a visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25:1605-1612.
36. Pyeon D., Lambert P.F., Ahlquist P. Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation. Proc. Natl. Acad. Sci. USA 2005, 102:9311-9316.
37. Raff A.B., Woodham A.W., Raff L.M., Skeate J.G., Yan L., Da Silva D.M., Schelhaas M., Kast W.M. The evolving field of human papillomavirus receptor research: a review of binding and entry. J. Virol. 2013, 87:6062-6072.
38. Rizk R.Z., Christensen N.D., Michael K.M., Muller M., Sehr P., Waterboer T., Pawlita M. Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types. J. Gen. Virol. 2008, 89:117-129.
39. Rossmann M.G. Fitting atomic models into electron-microscopy maps. Acta Crystallogr. D: Biol. Crystallogr. 2000, 56:1341-1349.
40. Rossmann M.G., Johnson J.E. Icosahedral RNA virus structure. Annu. Rev. Biochem. 1989, 58:533-569.
41. Rossmann M.G., Bernal R., Pletnev S.V. Combining electron microscopic with X-ray crystallographic structures. J. Struct. Biol. 2001, 136:190-200.
42. Rossmann M.G., Morais M.C., Leiman P.G., Zhang W. Combining X-ray crystallography and electron microscopy. Structure 2005, 13:355-362.
43. Smith T.J., Olson N.H., Cheng R.H., Chase E.S., Baker T.S. Structure of a human rhinovirus-bivalently bound antibody complex: implications for viral neutralization and antibody flexibility. Proc. Natl. Acad. Sci. USA 1993, 90:7015-7018.
44. Tang G., Peng L., Baldwin P.R., Mann D.S., Jiang W., Rees I., Ludtke S.J. EMAN2: an extensible image processing suite for electron microscopy. J. Struct. Biol. 2007, 157:38-46.
45. Tivol W.F., Briegel A., Jensen G.J. An improved cryogen for plunge freezing. Microsc. Microanal. Off. J. Microsc. Soc. Am. Microbeam Anal. Soc. Microsc. Soc. Can. 2008, 14:375-379.
46. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J.F., Peto J., Meijer C.J.L.M., Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189:12-19.
47. Wang Z., Christensen N., Schiller J.T., Dillner J. A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera. J. Gen. Virol. 1997, 78(Pt 9):2209-2215.
48. Wang Z., Raifu M., Howard M., Smith L., Hansen D., Goldsby R., Ratner D. Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 3' to 5' exonuclease activity. J. Immunol. Methods 2000, 233:167-177.
49. Wilson I.A., Stanfield R.L. Antibody-antigen interactions: new structures and new conformational changes. Curr. Opin. Struct. Biol. 1994, 4:857-867.
50. Wolf M., Garcea R.L., Grigorieff N., Harrison S.C. Subunit interactions in bovine papillomavirus. Proc. Natl. Acad. Sci. 2010, 107:6298-6303.
51. Wriggers W. Using Situs for the integration of multi-resolution structures. Biophys. Rev. 2010, 2:21-27.
52. Xiao C., Rossmann M.G. Interpretation of electron density with stereographic roadmap projections. J. Struct. Biol. 2007, 158:182-187.
53. Yan X., Sinkovits R.S., Baker T.S. AUTO3DEM - an automated and high throughput program for image reconstruction of icosahedral particles. J. Struct. Biol. 2007, 157:73-82.
54. Yan X., Dryden K.A., Tang J., Baker T.S. Ab initio random model method facilitates 3D reconstruction of icosahedral particles. J. Struct. Biol. 2007, 157:211-225.
55. Zhao Q., Modis Y., High K., Towne V., Meng Y., Wang Y., Alexandroff J., Brown M., Carragher B., Potter C.S., Abraham D., Wohlpart D., Kosinski M., Washabaugh M.W., Sitrin R.D. Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity. Virol. J. 2012, 9:52.
56. Zhao Q., Potter C.S., Carragher B., Lander G., Sworen J., Towne V., Abraham D., Duncan P., Washabaugh M.W., Sitrin R.D. Characterization of virus-like particles in GARDASIL® by cryo transmission electron microscopy. Hum. Vaccines Immunother. 2014, 10:734-739.